Landscapes / Companies
Biocity Biopharmaceutics Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
3
in active trials · 6 in all
Trials
4 active
11 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Dec 2026Phase 3 trial completes | |||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | IgA Nephropathy (IgAN) | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Cancer, Metastatic Solid Tumor and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Malignancies | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021